20/20 Biolabs enters 120-day standstill with investor Streeterville Capital.
The agreement forbids Investor for 120 days from converting preferred shares unless common stock exceeds Nasdaq minimum price by 10%. Market interpretation may center on the price trigger mechanics.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day